These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11940415)
1. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer]. Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415 [TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]. Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer]. García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910 [TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization. Iznaga-Escobar N; Ramos-Suzarte M; Morales-Morales A; Torres-Arocha L; Rodríguez-Mesa N; Pérez-Rodriguez R Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):687-96. PubMed ID: 15632954 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic efficacy and safety of 99mtc-labeled monoclonal antibody ior c5 in patients with colorectal and anal carcinomas: final report clinical trial phase I/II. Ramos-Suzarte M; Pintado AP; Mesa NR; Oliva JP; Iznaga-Escobar N; Aroche LT; Pimentel G; González J; Cordero M; Rodríguezi OT; Crombet RT; Pérez RR Cancer Biol Ther; 2007 Jan; 6(1):22-9. PubMed ID: 17224642 [TBL] [Abstract][Full Text] [Related]
7. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer. Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery. Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220 [TBL] [Abstract][Full Text] [Related]
9. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody. Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268 [TBL] [Abstract][Full Text] [Related]
11. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891 [TBL] [Abstract][Full Text] [Related]
13. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies. Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394 [TBL] [Abstract][Full Text] [Related]
15. [Radiolabeling of a new agent for the study of colorectal tumors]. Quesada Cepero W; Pimentel González G; Oliva González J; Pérez Tenorio G; Aguiar Cabeza E; Sánchez Monzón I; Hernández Romero O; Rebustillo Sierra M Rev Esp Med Nucl; 1998; 17(2):82-8. PubMed ID: 9611277 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice. Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y Ann Nucl Med; 1994 Feb; 8(1):23-30. PubMed ID: 8204394 [TBL] [Abstract][Full Text] [Related]
18. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist]. Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823 [TBL] [Abstract][Full Text] [Related]